Shares of Gilead Sciences Inc. rose 3.07% to $106.34 Monday, on what proved to be an all-around great trading session for the ...

The biotech Gilead Sciences has been the best-performing healthcare stock in the S&P 500 by far over the past 12 months. Its ...

Gilead Sciences offers steady dividend growth with a 2.99% yield. Read why the analyst nonetheless has a neutral rating on ...

The Handmaid's Tale' is inching towards its conclusion and June, Luke and Moira are putting their plans to take down Gilead ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...

A Morrow County man is facing dozens of charges, including pandering sexually-oriented material involving minors.

Canadian feminist author Margaret Atwood's work has long served as the inspiration for the American television adaptation The Handmaid's Tale, its first episode having been aired in 2017.

"The Handmaid's Tale" may be coming to an end, but the world of Gilead is not with a sequel, "The Testaments," in production ...

A former employee with a YMCA program is facing more than 40 charges of possessing child sexual abuse material. Dalton ...

The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

In The Handmaid's Tale season 6, June Osborne and Nick Blaine's tumultuous relationship is once again front and center.